Difference between revisions 166807058 and 166807059 on dewiki

< previous diff
next diff >
Benutzer:Verzettelung/Teva Pharmaceutical Industries
{{Use mdy dates|date=March 2015}}
{{Infobox company
|
  name   = Teva Pharmaceutical Industries Ltd.<br>{{lang|he|טבע תעשיות פרמצבטיות בע"מ}}
|
  logo   = [[Image:Teva Pharmaceutical Industries logo.png|250px]]
|
  type   = [[Public company|Public]]
(contracted; show full)==References==
{{Reflist|2|refs=

<ref name="21st Century&nbsp;— Global Leadership">http://www.tevapharm.com/about/history.asp The History of Teva</ref>

<ref name="Bayer Sues Teva and Barr for False Advertising">
{{cite web

| |title = =Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva’s Generic Oral Contraceptive Gianvi⏎
| url =  ⏎
 |url=http://pharma.bayer.com/scripts/pages/en/news_room/news_room/news_room95.php⏎
|  ⏎
 |author = =Bayer HealthCare Pharmaceuticals Inc.⏎
|  ⏎
 |date = =June 25, 2010⏎
|  ⏎
 |accessdate = =December 26, 2010 ⏎
 |deadurl=yes 
 |archiveurl=https://web.archive.org/web/20110103015518/http://pharma.bayer.com:80/scripts/pages/en/news_room/news_room/news_room95.php 
 |archivedate=January 3, 2011 
 |df=mdy 
}}</ref>

<ref name="tevanr2002">
{{cite web
| title = Teva news release hiring Israel Makov
| url = http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-newsArticle_Print&ID=1556547&highlight=
| author = Teva Pharmaceuticals Inc.
| date = February 14, 2002
| accessdate = September 28, 2014
}}</ref>

<ref name="ynet2006">
{{cite web
| title = Ynet reports Israel Makov resignation
| url = http://www.ynetnews.com/articles/1,7340,L-3316626,00.html
| author = Golan Hazani.
| date = October 18, 2006
| accessdate = September 28, 2014
}}</ref>

<ref name=biojerusalem>{{cite web⏎
⏎
 |url=http://www.biojerusalem.org.il/database_company.asp?ID=76  
 |title=Teva Pharmaceutical Industries—Jerusalem ⏎
 ⏎
 |work=Database ⏎
 ⏎
 |publisher=[[BioJerusalem]] ⏎
 ⏎
 |location=Jerusalem, Israel  
 |archiveurl=https://www.webcitation.org/5yXPfzOwLeb.archive.org/web/20110721143023/http://www.biojerusalem.org.il/database_company.asp?ID=76 ⏎
 |archivedate=May 8July 21, 2011 ⏎
 ⏎
 |accessdate= ⏎
 |deadurl=yes 
 |df=mdy ⏎
}}</ref>

<ref name=bloomberg2jan2012>{{Cite news | agency=Bloomberg News | date=January 2, 2012 |title=Teva Names a New Chief Executive | work=[[The New York Times]] | department=Business Day | url=http://www.nytimes.com/2012/01/03/business/teva-names-a-new-chief-executive.html | accessdate=January 3, 2012 | archivedate=April 27, 2012 | archiveurl=https://web.archive.org/web/20120427040309/http://www.nytimes.com/2012/01/03/business/teva-names-a-new-chief-executive.html }}{{registration required(contracted; show full)

<ref name=geneng20140215p10>{{cite news | title=Teva Outbids Endo, Acquires NuPathe for $144M+ | department=News: Industry Watch | type=paper | work=[[Gen. Eng. Biotechnol. News]] | page=10 | date=February 15, 2014 | volume=34 | issue=4 }}</ref>

<ref name=genericprotonixlaunch>{{cite web|url=http://www.tevapharm.com/pr/2007/pr_708.asp
  |title=Teva Announces Launch Of Generic Protonix Tablets  |work=tevapharm.com |deadurl=yes |archiveurl=https://web.archive.org/web/20071229041600/http://www.tevapharm.com:80/pr/2007/pr_708.asp |archivedate=December 29, 2007 |df=mdy }}</ref>

<ref name="Gianvi Pharmacist Letter">{{cite web|title=Microsoft Word&nbsp;– Gianvi Pharmacist Letter&nbsp;– RevD&nbsp;– Final 7-1-10&nbsp;– web versi... |author=Maureen M Cavanaugh, Teva Pharmaceuticals |url=http://www.tevausa.com/assets/base/products/Gianvi_Letter_7-1-10.pdf |date=July 1, 2010 |accessdate=December 26, 2010 |deadurl=yes |archiveurl=https://web.archive.org/web/20120314145028/http://www.tevausa.com/assets/base/products/Gianvi_Letter_7-1-10.pdf |archivedate=March 14, 2012 }}</ref>

<ref name=hollisfiercepharma2010>{{cite web
 |url=http://www.fiercepharma.com/special-reports/top-10-generic-drug-companies-2010/teva-top-10-generic-drug-companies-2010  
 |title=Teva&nbsp;– Top 10 Generic Drug Companies 2010 ⏎
 ⏎
 |first=Liz Jones ⏎
 ⏎
 |last=Hollis ⏎
 ⏎
 |date=August 10, 2010 ⏎
 ⏎
 |work=FiercePharma  
 |publisher=[[FierceMarkets]] ⏎
 ⏎
 |location=Washington, DC, United States ⏎
 ⏎
 |accessdate=November 3, 2010  
 |archiveurl=http://www.webcitation.org/5yXPMLkBa |archivedate=May 8, 2011 ?url=http://www.fiercepharma.com/special-reports/top-10-generic-drug-companies-2010/teva-top-10-generic-drug-companies-2010 
 |archivedate=May 8, 2011 
 |deadurl=yes 
 |df=mdy ⏎
}}</ref>

<ref name=KGPTM2011>{{cite news
 |title=Teva plans $500 million Japan acquisition ⏎
 ⏎
 |first=Kevin ⏎
 ⏎
 |last=Grogan  
 |url=http://www.pharmatimes.com/Article/11-05-05/Teva_plans_500_million_Japan_acquisition_-_Nikkei.aspx  
 |newspaper=[[PharmaTimes Magazine]] ⏎
 ⏎
 |location=London, England ⏎
 ⏎
 |date=May 5, 2011 ⏎
 ⏎
 |at=Online PharmaTimes  
 |accessdate=May 7, 2011 ⏎
 ⏎
 |archiveurl=http://www.webcitation.org/5yVp5Pr7b |archivedate=May 7, 2011 ?url=http://www.pharmatimes.com/Article/11-05-05/Teva_plans_500_million_Japan_acquisition_-_Nikkei.aspx 
 |archivedate=May 7, 2011 
 |deadurl=yes 
 |df=mdy ⏎
}}</ref>

<ref name=levinresig>
{{Cite news
| |title = =Teva CEO Jeremy Levin steps down⏎
|  ⏎
 |work = =Globes⏎
|  ⏎
 |accessdate = =October 30, 2013⏎
| url =  ⏎
 |url=http://www.globes.co.il/serveen/globes/docview.asp?did=1000889846 
 |deadurl=yes 
 |archiveurl=https://web.archive.org/web/20131104152001/http://www.globes.co.il/serveen/globes/docview.asp?did=1000889846 ⏎
 |archivedate=November 4, 2013 
 |df=mdy 
}}</ref>

<ref name=reuters20140109>{{cite news | title=Israel's Teva Pharm names Vigodman as CEO | agency=Reuters | url=http://www.reuters.com/article/2014/01/09/tevapharm-ceo-idUSL6N0KJ0LT20140109 | date=January 9, 2014 | deadurl=no | archivedate=January 9, 2014 | archiveurl=https://web.archive.org/web/20140109120239/http://www.reuters.com/article/2014/01/09/tevapharm-ceo-idUSL6N0KJ0LT20140109 }}</ref>

<ref name="Teva employees gain $222m on options">{{cite news |title=Teva employees gain $222m on options |first=Koby |last=Yeshayahou |url=http://www.globes.co.il/serveen/globes/docview.asp?did=1000623808&fid=1725 |newspaper=[[Globes]] |publisher=[[Globes Publisher Itonut]] |location=Rishon Le-Zion, Israel |date=February 16, 2011 |at=globes-online.com |accessdate= |archiveurl=http://www.webcitation.org/5yXQENLt8 |archivedate=May 8, 2011 }}</ref>

<ref name="Teva to Acquire Generics Firm">{{cite news  |title=Teva to Acquire Generics Firm |author=Jonathan D. Rockoff |author2=Eyk Henning |url=http://online.wsj.com/article/SB10001424052748704207504575129240833529842.html |format=~100 words |newspaper=[[The Wall Street Journal]] |location=New York City |date=March 19, 2010 |at=WSJ.com |accessdate=May 8, 2011 |archiveurl=http://www.webcitation.org/5yXX2YMH8?url=http://online.wsj.com/article/SB10001424052748704207504575129240833529842.html |archivedate=May 8, 2011 |deadurl=yes |df=mdy }}</ref>

<ref name=reuters>{{Cite news | title=Teva Pharmaceutical Industries Ltd (TEVA.O) Officers | publisher=Reuters | accessdate=October 11, 2008 | archivedate=September 29, 2008 | url=http://www.reuters.com/finance/stocks/officerProfile?symbol=TEVA.O&officerId=132712 | archiveurl=https://web.archive.org/web/20080929214726/http://www.reuters.com/finance/stocks/officerProfile?symbol=TEVA.O&officerId=132712 }}</ref>

<ref name=singernyt2010>{{cite news |first=Natasha |last=Singer |date=March 18, 2010
 |url=http://www.nytimes.com/2010/03/19/business/global/19drugs.html |accessdate=March 18, 2010
 |title=Teva to Acquire Top German Generics Maker for $5 Billion |newspaper=[[The New York Times]] }}</ref>

<ref name="Teva Completes Acquisition of Barr">{{cite web|url=http://www.tevapharm.com/pr/2008/pr_813.asp  |title=Teva Completes Acquisition of Barr  |work=tevapharm.com |deadurl=yes |archiveurl=https://web.archive.org/web/20090124234703/http://tevapharm.com:80/pr/2008/pr_813.asp |archivedate=January 24, 2009 |df=mdy }}</ref>

<ref name="Teva to acquire Ratiopharm in deal valued near $5 billion">{{cite web  |url=http://www.marketwatch.com/story/teva-near-478-bln-deal-for-ratiopharm-reports-2010-03-18 |title=Teva to acquire Ratiopharm in deal valued near $5 billion |author=Robert Daniel |author2=Polya Lesova   |date=March 18, 2010 |work=[[MarketWatch]] |publisher=[[Dow Jones & Co.]] |location=New York City |archiveurl=http://www.webcitation.org/5yXXk8ZU2?url=http://www.marketwatch.com/story/teva-near-478-bln-deal-for-ratiopharm-reports-2010-03-18 |archivedate=May 8, 2011 |accessdate=May 8, 2011 |deadurl=yes |df=mdy }}</ref>

<ref name="Teva to Buy Cephalon for $6.8 Billion">{{cite news| url=http://dealbook.nytimes.com/2011/05/02/teva-to-buy-cephalon-for-6-8-billion/?partner=rss&emc=rss | work=The New York Times | first=Chris V. | last=Nicholson | title=Teva to Buy Cephalon for $6.8 Billion | date=May 2, 2011}}</ref>

<ref name="Teva won't make more of powerful sedative">{{cite web | title = Teva won't make more of powerful sedative | url = http://www.msnbc.msn.com/id/37403276/ns/health-health_care/}}</ref>

<ref name="Solid dosage forms that contain clathrates">
{{cite web
| |title = =Solid dosage forms that contain clathrates of 17.alpha.-ethinyl estradiol⏎
| url =  ⏎
 |url=http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=5798338.PN.&OS=PN/5798338&RS=PN/5798338⏎
|  ⏎
 |author = =Backensfeld ⏎
 ⏎
 |  date = =August 25, 1998⏎
|  ⏎
 |accessdate = =December 26, 2010⏎
⏎
 ⏎
  ⏎
 |display-authors=etal ⏎
}}{{dead link|date=December 2016 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>

<ref name="Yahoo deadlink">[http://news.yahoo.com/s/nm/20100318/bs_nm/us_ratiopharm Ratiopharm]  {{dead link|date=June 2016|bot=medic}}{{cbignore|bot=medic}}</ref>

<ref name=yanairesign>
{{Cite news
| title = Teva CEO Shlomo Yanai leaving in May, to be replaced by American
| work = Haaretz
(contracted; show full)[[Category:Science and technology in Israel]]
[[Category:Companies formerly listed on NASDAQ]]
[[Category:Generic drug manufacturers]]
[[Category:Israeli brands]]
[[Category:Economy of Jerusalem]]
[[Category:Life sciences industry]]
[[Category:Companies based in Petah Tikva]]
[[Category:Multinational companies headquartered in Israel]]